Primary Crystallization’s Influence on Fluticasone DPIs

Discover the impact of crystallization on mechanical properties & secondary processing of Fluticasone Propionate in dry powder inhaler formulations.

Pulmonary Fate of Fluticasone: Challenges Met

Nanopharm investigate the pulmonary effect of Fluticasone and related compounds, addressing physiologic and pharmacokinetic challenges.

Unraveling the Pulmonary Fate of Fluticasone and Friends: Meeting the Physiologic and Pharmacokinetic Challenges

Exploring the role of DPI (Dry powder inhaler) in drug development and the inhalation process and pharmacokinetics of fluticasone propionate.

The Influence of Secondary Processing on the Structural Relaxation Dynamics of Fluticasone Propionate

Nanopharm explores structural dynamics of Fluticasone Propionate in DPIs. Focus on APSD in Dry Powder Inhaler formulations.

Structural Dynamics of Fluticasone Propionate Processing

Nanopharm explores the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate.

Secondary Processing’s Effect on Fluticasone Dynamics

Explore the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate in DPIs.